Immunic, Inc. (IMUX)
14.01
+1.04
(+8.02%)
USD |
NASDAQ |
May 27, 16:00
14.01
0.00 (0.00%)
After-Hours: 17:43
Immunic EPS Diluted (Quarterly) : -1.081 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Sarepta Therapeutics, Inc. | 2.878 |
| ImmunityBio, Inc. | -0.6162 |
| Mineralys Therapeutics, Inc. | -0.4749 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.59M |
| Total Expenses (Quarterly) | 32.59M |
| Enterprise Value | -9.537M |
| Earnings Yield | -43.06% |
| Normalized Earnings Yield | -43.06 |